title: ZK-807834. Berlex.
abstract: Berlex (a Schering subsidiary) and Pfizer (formerly Parke-Davis) are developing ZK-807834 (CI-1031), one of a series of Factor Xa inhibitors, for the potential parenteral treatment of unstable angina pectoris.
authors.affiliation: Millennium Pharmaceuticals Inc, 256 East Grand Avenue, South San Francisco, CA 94080, USA. uma.sinha@mpi.com
authors.forename: Uma
authors.initials: U
authors.lastname: Sinha
mesh_terms: D000578:Amidines / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000188:drug therapy; D000818:Animals; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D004345:Drug Industry / Q000331:legislation & jurisprudence / Q000379:methods*; D006801:Humans; D011725:Pyridines / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D000578:Amidines; D011725:Pyridines; C114592:Fidexaban